Clinical Trial Update: Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1-2 trial evaluating the combination of azacitidine and lenalidomide in previously untreated elderly patients with acute myeloid leukemia, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Stanford University | Conditions: Acute Myeloid Leukemia (AML), Adult Acute Myeloblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-20